Recombinant CCL2 (Carlumab Biosimilar) antibody

Catalog No. ABIN7581271

The Human Monoclonal anti-CCL2 (Carlumab Biosimilar) antibody has been validated for ELISA, FACS, BLI, Func and SPR. It is suitable to detect CCL2 (Carlumab Biosimilar) in samples from Human.

Quick Overview for Recombinant CCL2 (Carlumab Biosimilar) antibody (ABIN7581271)

Target: CCL2 (Carlumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CCL2 (Carlumab Biosimilar) antibody is un-conjugated

Application: ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-CCL2 (Carlumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-CCL2 / MCP1 Reference Antibody (carlumab)

Characteristics: Anti-CCL2 / MCP1 Reference Antibody (carlumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for CCL2 (Carlumab Biosimilar)

Target: CCL2 (Carlumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P13500